# Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients

> **NCT02456051** · — · TERMINATED · sponsor: **University of Roma La Sapienza** · enrollment: 21 (actual)

## Conditions studied

- Diabetes Mellitus, Adult-Onset
- Diabetes Complications
- Carcinoma, Pancreatic Ductal
- Pancreatic Neoplasm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02456051
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** enrollment was terminated because of the poor recruitment rate
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456051, "Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02456051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*